We have a couple more articles out, now.
https://iceni.substack.com/p/covid-19-deep-dive-part-v-human-traffickershttps://iceni.substack.com/p/covid-19-deep-dive-part-vi-technocracy-787This rabbit hole keeps getting darker and darker, the deeper we dig. Not only were the Ukraine labs real, and indeed, DTRA-funded, Metabiota and EcoHealth Alliance are directly connected to each other. However, they aren't the only DTRA-funded labs. There's also the Lugar Center in T'bilisi, Georgia, as well as labs scattered all over the globe:
https://silview.media/2021/06/03/us-ran-grewsome-bioweapon-research-in-over-25-countries-wuhan-tip-of-an-iceberg-ecohealth-alliance-implicated-again/Hi Spartacus,
I used to read
http://vaccinepapers.org pretty regularly, and I'm guessing that you (or some of you) did as well. VP kinda went dark/silent about the time they kicked off the scamdemic. Good reference data on the site at least.
There is so much BS floating around these days, and a fair bit of it seems to be psychological operations of one flavor or another. ICENI is similar to VP in terms of technical level and I appreciate it. It would be kind of nice to get your input on other sources which identify and evaluate papers at a similar level, rigor, and skepticism. And, or course, are not afraid to cross over into 'crime think' when it comes to rationally hypothesizing about the players and motives behind some of the observations.
There are many possible mechanisms of injury with these COVID-19 vaccines, particularly the mRNA vaccines.
- The lipid nanoparticles, themselves, can cause rare extreme allergic reactions/anaphylaxis.
- The lipid nanoparticles don't actually stay in the shoulder muscle; leaked biodistribution studies from Japan show that they accumulate all over the body.
- Unlike the virus, which mostly infects cells expressing ACE2 proteins, these lipid nanoparticles have the ability to transfect ANY cell line they encounter with mRNA for SARS-CoV-2 Spike.
- The nucleoside-modified (pseudouridylated) mRNA evades detection by toll-like receptors of the 7 and 8 types, but it may actually be blocking them, inhibiting their normal function (toll-like receptors are used by the body to detect signs of damage and respond with inflammation).
- Nucleoside-modified mRNA is resistant to breakdown by nucleases and may persist in the body for an extended period of time.
- The synthetic caps of the mRNA may be toxic to mitochondria, triggering cytochrome C oxidase deficiency and mitochondrial deafness.
- The mRNA encoding the Spike may be integrated into the genome by endogenous reverse transcription.
- The Spike in the vaccine is supposedly made inert by the insertion of prolines on the S2 side of the S1/S2 cleavage site. However, human membrane-bound proteases are still cleaving the Spike, causing the S1 subunit to float away into the bloodstream. It's not inert.
- SARS-CoV-2 Spike S1 subunits can, on their own, even without the rest of the Spike, penetrate the blood-brain barrier by permeabilizing the vascular endothelium.
- The SARS-CoV-2 S1 receptor binding domain has a heparin-binding motif that can aggregate amyloid. Amyloid plaques are typical in neurodegenerative diseases like Alzheimer's.
- SARS-CoV-2 Spike has a region with superantigenic properties.
- SARS-CoV-2 Spike can localize in cell nuclei and inhibit V(D)J recombination. If this happened in T and B cell precursors, it would cause T and B lymphopenia and immunodeficiency.
We have refs for all this, too:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849378/https://www.docdroid.net/xq0Z8B0/pfizer-report-japanese-government-pdfhttps://www.frontiersin.org/articles/10.3389/fchem.2020.589959/fullhttps://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1https://www.frontiersin.org/articles/10.3389/fcell.2021.789427/fullhttps://ncbi.nlm.nih.gov/pmc/articles/PMC6453560/https://archive.ph/P7FNZhttps://pubmed.ncbi.nlm.nih.gov/34670143/https://www.mdpi.com/1467-3045/44/3/73/htmhttps://academic.oup.com/cid/article/74/4/715/6279075?login=falsehttps://pubmed.ncbi.nlm.nih.gov/33328624/https://www.sciencedirect.com/science/article/pii/S0006291X2100499X?via%3Dihubhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568239/https://www.mdpi.com/1999-4915/13/10/2056